Abstract
Personality traits and temperament may affect sports performance. Previous studies suggest that dopamine may play an important role in behavior regulation and physical exercise performance. The aim of this study is to determine associations between dopamine D4 receptor gene (DRD4 Ex3) polymorphisms and personality traits (such as neuroticism, extraversion, openness, agreeability and conscientiousness) in elite combat athletes. A total of 302 physically active, unrelated, self-reported Caucasian participants were recruited for this study. The participants consisted of 200 elite male combat athletes and 102 healthy male participants (control group). For personality trait measurements, the NEO Five-Factor Personality Inventory (NEO-FFI) and the State-Trait Anxiety Inventory questionnaires were used. For the genetic assays, blood was collected and all samples were genotyped using the real-time PCR method. A 2 x 3 factorial ANOVA revealed statistically significant differences on the Openness NEO Five Factor Inventory scale for both examined factors, i.e. sport status and genetics DTD4 Ex3. Combat athletes achieved higher scores on the Conscientiousness NEO-FFI scale when compared to controls (7.18 vs 5.98). On the other hand, combat athletes scored lower on the Openness scale in comparison with control group (4.42 vs. 4.63). Subjects with the DRD4 Ex3 s/s genotype had lower results on the openness scale in comparison with participants with the DRD4 Ex3 s/1 genotype (4.01 vs. 4.57) and higher DRD4 Ex3 1/1 genotype (4,01 vs. 3,50). In conclusion, we found an association between the dopamine D4 receptor gene in variable number tandem repeat (VNTR) polymorphisms and athletic status for two NEO-FFI factors: Openness and Conscientiousness. The DRD4 exon 3 polymorphism may be associated with the selected personality traits in combat athletes, thereby modulating athletes’ predisposition to participate in high risk sports.
Keywords: Elite athletes, Dopamine, D4 receptor, Personality traits, Genetics
INTRODUCTION
Dopamine is the hormone of “motivation, thrill and adventure seeking” [1]. The influence of dopamine is associated with making so called “risky decisions”. The next element that should be acknowledged as important is the so called “mesolimbic reward system” which mediates the reward psychopharmacology response to physical effort or other factors. Dopamine, described as a “pleasure neurotransmitter,” is functionally connected with the “pleasure center,” located in the ventral tegmental area of the brain in which there are neurons of the dopaminergic system and nucleus accumbent [2]. Hence, the system seems to be one of the key factors in starting and continuing training. It seems that the interactions between genetically conditioned temperament and environmentally conditioned character, are factors influencing will to participate in and continue with sport training, which consequently affect achievement of success in this area [3,4]. Hence, ontogenetic differences result from the modulatory influence of the neurotransmitter system on expression of particular personality traits among others. This example of such modification could be a shortage of dopamine that results in significantly influencing “novelty-seeking” behaviors expressed in the form of constantly searching for new “thrills”. The effect is functional modification of dopaminergic system [5,6,7,8]. Another factor which exerts influence by modulating the dopaminergic pathway, and consequently sporting achievement, is visual perception, which is probably one of the key determinants in combat sports. Dopamine, which is a chemical analogue of light, affects the paracrine neurotransmitter in the retina, whereas receptors D2 and D4 of photoreceptor cells control illumination-related processes, among which melatonin biosynthesis, opsin expression in cone cells or the level of cAMP inside receptors [9] are included.
Personality significantly influences behavior, life-style and also the maintenance of healthy habits in a lifetime. Current research concerning personality concentrates on the model that is constructed of the so called Big Five [10,11,12,13], which consists of: Openness, Conscientiousness, Extraversion, Agreeableness and Neuroticism domains. These 5 traits isolate differences among people which influence emotions, motivation and cognition [14]. Currently, to analyze these personality traits, the NEO personality inventory (NEO-FFI) is employed.
The high novelty-seeking or ‘risk-taking’ personality trait was previously correlated with genetic variants within genes encoding dopamine receptors [15]. These dopamine receptors, including D2 and D4 receptor subtypes, are involved in dopamine neurotransmission and may modulate memory, behaviour and executive function [16]. It has also been suggested that dopamine neurotransmission is connected with novelty-seeking [17,18], which is defined as “excitement to novel stimuli” in relation with dependence [19,20] and relapse [21]. Also, extraversion is a trait connected with the functioning of the dopaminergic system. As dual research shows, the traits are related with genetics in different ranges – from 25% to 61% [21, 22]. Both novelty-seeking and extraversion are correlated with receptor 4 of the dopamine gene (DRD4) as indicated in research on healthy [23] and research dependent [24] subjects. However, other research does not seem to confirm this association [25].
The DRD4 gene encodes the dopamine D4 receptor and is expressed in the cognitive and emotional areas of the limbic system and is located on chromosome 11 (locus p15.5). A variable number of tandem repetitions (VNTR) located in the 3rd exon is one of the most frequently investigated polymorphisms of the gene. To date, association has been demonstrated for 2 of the 10 repeated 48bp sequence variants, showing influence on length of the third intracellular loop receptor D4. Interestingly, polymorphic variants influence the expression of these genes in a different manner [26]. Asghari [27], in his work, indicates diversified sensitivity in relation to endogenous dopamine depending on the length of the variant coding for the particular receptor. Dopamine transporter gene DAT1, which is another key element of the dopaminergic system, is located in chromosome 5 (p15.3). The most frequently investigated variant is the VNTR polymorphism located in 3’ UTR region. The 40bp sequence of 3 to 13 repetitions was identified, however, the most frequently occurring variants had 9 or 10 repeated sequences [28]. Nevertheless, contradictory reports concerning polymorphic variants and DAT1 transcription level were also observed in this case [29,30].
The goal of the present study was to investigate the personality traits in elite combat athletes and healthy controls with respect to variable number of tandem repeats (a 48 bp unit) in the third exon of the DRD4 gene.
MATERIALS AND METHODS
Materials
The study was conducted among healthy (non-dependent and non-psychosis) 200 Polish male combat athletes aged 22.9 ± 4.2 (judo, n = 51; wrestling, n = 38; boxing, n = 50, kickboxing, n = 32; karate, n = 29). All of them were ranked in the top 10 nationally in their respective disciplines. The study population included 16 athletes classified as ‘top-elite’ (gold medalists in the World and European Championships, World Cups or Olympic Games) and 68 athletes classified as ‘elite’ (silver or bronze medalists in the World and European Championships, World Cups or Olympic Games). The others (n=69) were classified as ‘sub-elite’ (participants in international competitions, with no less than 8 years experience). Various methods were used to obtain the samples, including targeting national teams and providing information to national coaching personnel and athletes attending training camps.
Controls included 102 unrelated, healthy (non-dependent and non-psychosis) Polish male volunteers aged 21.6±2.6. All athletes and controls were Caucasian to reduce the possibility of racial gene skewing and to overcome any potential problems due to population stratification.
Ethical approval
The procedures followed in the study were conducted in accordance with the principles of the World Medical Association Declaration of Helsinki and were approved by the Bioethics Committee for Clinical Research at the Regional Medical Chamber in Gdansk, Poland. All participants were provided with an information sheet concerning study particulars, including the purpose of the study and the procedures involved, in addition to the possible risks and benefits associated with participation. All participants provided written informed consent to genotyping with the understanding that it was anonymous and that the obtained results would be confidential.
Methods
Personality Traits
All participants were tested using the NEO Five-Factor Personality Inventory (NEO-FFI) and, the State-Trait Anxiety Inventory (STAI) questionnaires. The results of these were both given on the sten scale.
The NEO Five Factor Inventory questionnaire is used to diagnose personality traits, which are included in the five-factor model defined by the Big Five model (neuroticism, extraversion, openness, conscientiousness and agreeableness). The questionnaire consists of 60 statements (of self-reported character), which require the participant to examine one’s attitude toward one’s own self. The Anxiety Inventory (STAI) questionnaire is used to examine anxiety, which is understood as conditionally and transiently conditioned condition of the individual and anxiety, understood as a relatively constant personality trait. The STAI questionnaire consists of two independent subscales, each of which contains 20 statements, one (X-1) measures anxiety-state and the other (X-2) measures an anxiety-trait.
Genetic analyses
For the genetic assays, blood was collected into tubes with EDTA (anticoagulant). Data Collection Genomic DNA from peripheral blood leukocytes was extracted using a High Pure Polymerase Chain Reaction (PCR) Template Preparation extraction kit (Roche Diagnostics, Mannheim, Germany). The extraction was performed according to the manufacturer’s instructions. DNA sample were stored at 4°C for further analysis.
The genomic DNA was isolated from venous blood according to standard procedures. Samples were genotyped using the PCR method. The DRD4 genotypes were grouped based on the presence of the short (2–5 repeat) and long (6–11 repeat) variants. Genotyping was performed using the PCR-VNTR method, using primers: F: 5 0 -GCG ACT ACG TGG TCT ACT CG 3 0, R: 5 0 -AGG ACC CTC ATG GCC TTG 3 0; in the final volume of 25 μL PCR mix per reaction, with l00 ng genomic DNA, 10 pmol of primers, 50 mM KCl, 10 mM TrisHCl, 1.5 mM MgCl2, 200 μM dATP, dCTP, dTTP, dGTP and 0.8 U of the Tag polymerase. Conditions for reaction: 3 min. of initial denaturation in 95°C, cycling 30 s. of denaturation in 95°C, 1 min. of primers hybridization in 63°C and 30 s. of elongation in 72°C, repeated in 35 cycles, 5 min. of final elongation in 72°C. The amplified products were visualized using ethidium bromide stained gel electrophoresis (3% agarose) and UV photography. The products ranged from 379 bp (2 repeats) to 811 (11 repeats). The products were divided into 2 groups: short alleles (S, 2–5 repeats) and long alleles (L, 6–11 repeats).
Statistical analysis
Concordance between the genotype frequency distribution and Hardy-Weinberg equilibrium (HWE) was tested with the HWE software (http://www.oege.org/software/hwe-mr-calc.html) [31]. DRD4 genotype frequencies between control subjects and cases were tested using Chi square test. The relationship between DRD4 variant, group assignment (elite athletes vs controls) and NEO Five Factor Inventory (NEO-FFI) or STAI sten scores were analyzed using 2 x 3 factorial ANOVA. The Tukey HSD post-hoc tests were conducted to determine if the interaction term was significant. All computations were performed using STATISTICA 13 (Tibco Software Inc, Palo Alto, CA, USA) for Windows (Microsoft Corporation, Redmond, WA, USA).
RESULTS
The observed DRD4 Ex3 VNTR polymorphism frequencies did not differ from expectations based on Hardy-Weinberg theorem, neither in the elite athletes (Table 1, p=0.094), nor in the control group (Table 2, p=0.192). There were no significant differences between cases and controls with respect to genotypes (p=0.090) and alleles (p=0.669) (Table 3).
TABLE 1.
Hardy-Weinberg’s law for the athletes subjects.
| Hardy-Weinberg equilibrium calculator including analysis for ascertainment bias | Observed (Expected) | Test χ2 |
|||
|---|---|---|---|---|---|
| χ2 | P | ||||
| DRD4 Ex3 | l/l | 6 (10.1 | s allele freq = 0.78 l allele freq = 0.22 |
2.80 | >0,05 |
| s/l | 78 (69.7) | ||||
| s/s | 116 (120.1) | ||||
TABLE 2.
Hardy-Weinberg’s law for the control subjects.
| Hardy-Weinberg equilibrium calculator including analysis for ascertainment bias | Observed (Expected) | Test χ2 |
|||
|---|---|---|---|---|---|
| χ2 | p | ||||
| DRD4 Ex3 | s/l | 28 (32.1) | s allele freq = 0.8 l allele freq = 0.2 |
1.7 | >0,05 |
| s/s | 68 (65.9) | ||||
| l/l | 6 (3.9) | ||||
TABLE 3.
Frequency of genotypes and alleles of the DRD4 Ex3 genes polymorphisms in athletes and in controls.
| Group | DRD4 Ex3 | |||||
|---|---|---|---|---|---|---|
| Genotypes | Alleles | |||||
| s/l N(%) |
s/s N(%) |
l/l N(%) |
s N(%) |
l N(%) |
||
| Athletes | 78 | 116 | 6 | 310 | 90 | |
| N=200 | (0.39) | (0.58) | (0.03) | (0.78) | (0.22) | |
| Control | 28 | 68 | 6 | 164 | 40 | |
| N=102 | (0.27) | (0.67) | (0.06) | (0.80) | (0.20) | |
| χ2 | 4.81 | .67 | ||||
| p value | .090 | .413 | ||||
p-statistical significance χ2 test, N- number of subjects
Significant between-group differences are marked in bold print.
The results of 2x3 factorial ANOVA of the NEO Five-Factor Personality Inventory (NEO-FFI) and the State-Trait Anxiety Inventory (STAI) sten scales are summarized in Table 4. We found a significant result when comparing groups (elite athletes vs controls) for Openness (F1,296=16.3, p=0.00007) and Conscientiousness (F1,296=10.3, p=0.001), accounting for 5.2% and 3.4% of variance, respectively. In addition to those findings, we found group x DRD4 genotype interactions: for Openness (Figure 1, F2,296=5.01, p=0.007) and Conscientiousness (Figure 2, F2,296=4.18, p=0.016) responsible for 3.3% and 2.7% phenotypic variation, respectively. Post-hoc analysis is shown in Table 5.
TABLE 4.
STAI and NEO Five Factor Inventory results between healthy control and athletes.
| STAI / NEO Five Factor Inventory/ (sten scale) | Athletes (N = 200) | Control (N = 102) | t p value |
Cohen’s d |
|---|---|---|---|---|
| STAI ST | 4.90± 2.22 | 4.73±2.14 | .688 | .08 |
| STAI C | 5.28±2.37 | 5.20±2.00 | .848 | .04 |
| Neuroticism/scale | 4.84±2.30 | 4.82±1.72 | .967 | .01 |
| Extraversion/scale | 6.20±1.88 | 6.14±1.78 | .864 | .03 |
| Openness/scale | 4.42±1.62 | 4.63±1.75 | .538 | .12 |
| Agreeability/scale | 5.18±2.13 | 5.51±1.88 | .411 | .16 |
| Conscientiousness/scale | 7.18±1.92 | 5.98±1.79 | .002 | .65 |
p-statistical significance t-Student’s test, N- number of subjects
Significant between-group differences are marked in bold print.
FIG. 1.
The group (elite athletes vs healthy controls) x DRD4 Ex3 polymorphism interaction for the NEO Five Factor Inventory scale of Openness.
FIG. 2.
The group (elite athletes vs healthy controls) x DRD4 Ex3 polymorphism interaction for the NEO Five Factor Inventory scale of Conscientiousness.
TABLE 5.
Differences in DRD4 Ex3 and STAI /NEO Five Factor Inventory between healthy control subjects and athletes.
| STAI /NEO Five Factor Inventory (sten scale) | DRD4 Ex3 | Main Effects ANOVA | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Athletes (N = 200) | Control (N = 102) | s/l (N = 106) | s/s (N = 184) | l/l (N = 12) | full model | Main Effects | ||||
| F (p value) | factor | F (p value) | ɳ2 | power (alfa = 0,05) | ||||||
| STAI ST | 4.90 ± 2.22 | 4.72 ± 2.14 | 4.45 ± 2.73 | 4.61 ± 2.65 | 3.75 ± 2.18 | F5,296=.389 p=.865 R2=.007 |
intercept | F1,296=223 (p=.000) | .430 | 1.000 |
| sport/control | F1,296=.0003 (p=.987) | 1e-6 | .050 | |||||||
| DRD4 Ex3 | F2,296=.65 (p=.525) | .004 | .158 | |||||||
| sport/control x DRD4 Ex3 | F2,296=0.12 (p=.883) | .0008 | .069 | |||||||
| STAI C | 5.28 ± 2.37 | 5.20 ± 2.00 | 4.93 ± 2.56 | 4.97 ± 2.91 | 4.25 ± 2.18 | F5,296=.557 p=.733 R2=.009 |
intercept | F1,296=252 (p=.000) | .460 | 1.000 |
| sport/control | F1,296=.34 (p=.560) | .001 | .089 | |||||||
| DRD4 Ex3 | F2,296=.31 (p=.735) | .0002 | .099 | |||||||
| sport/control x DRD4 Ex3 | F2,296=.08 (p=.922) | .0006 | .062 | |||||||
| NEO FFINeuroticism/scale | 4.84 ± 2.30 | 4.82 ± 1.72 | 4.63 ± 2.62 | 4.16 ± 2.44 | 3.25 ± 2.60 | F5,296=1.14 p=.338 R2=.019 |
intercept | F1,296=223 (p=.000) | .430 | 1.000 |
| sport/control | F1,296=.04 (p=.837) | .0001 | .054 | |||||||
| DRD4 Ex3 | F2,296=2.08 (p=.127) | .014 | .426 | |||||||
| sport/control x DRD4 Ex3 | F2,296=0,17 (p=.843) | .001 | .076 | |||||||
| NEO FFIExtraversion/scale | 6.20 ± 1.88 | 6.14 ± 1.78 | 5.44 ± 2.64 | 5.40 ± 2.39 | 6.67 ± 3.03 | F5,296=1.02 p=.406 R2=.017 |
intercept | F12965=473 (p=.000) | .615 | 1.000 |
| sport/control | F1,296=1.18 (p=.278) | .004 | .192 | |||||||
| DRD4 Ex3 | F2,296=1.57 (p=.209) | .011 | .333 | |||||||
| sport/control x DRD4 Ex3 | F2,296=0.13 (p=.878) | .0009 | .070 | |||||||
| NEO FFIOpenness /scale | 4.42 ± 1.62 | 4.63 ± 1.75 | 4.57 ± 2.39 | 4.01 ± 2.01 | 3.50 ± 2.54 |
F5,296=4.48 p=.0006 R2=.070 |
intercept | F1,296=331 (p=.000) | .528 | 1.000 |
| sport/control | F1,296=16.3 (p=.00007) | .052 | .981 | |||||||
| DRD4 Ex3 | F2,296=3.80 (p=.023) | .025 | .689 | |||||||
| sport/control x DRD4 Ex3 | F2,296=5.01 (p=.007) | .033 | .812 | |||||||
| NEO FFIAgreeability/scale | 5.18 ± 2.13 | 5.51 ± 1.88 | 5.03 ± 2.64 | 5.56 ± 2.56 | 5.00 ± 1.86 | F5,296=0.684 p=.636 R2=.011 |
intercept | F1,296=358 (p=.000) | .548 | 1.000 |
| sport/control | F1,296=.005 (p=.941) | .00002 | .051 | |||||||
| DRD4 Ex3 | F2,296=1.66 (p=.192) | .011 | .349 | |||||||
| sport/control x DRD4 Ex3 | F2,296=1.06 (p=.853) | .001 | .074 | |||||||
| NEO FFIConscientiousness/scale | 7.18 ± 1.92 | 5.98 ± 1.79 | 6.10 ± 2.46 | 6.23 ± 2.59 | 6.33 ± 2.46 |
F5,296=6.85 p=.000005 R2=.104 |
intercept | F1,296=569 (p=.000) | .658 | 1.000 |
| sport/control | F1,296=10.3 (p=.001) | .034 | .892 | |||||||
| DRD4 Ex3 | F2,296=0.14 (p=.868) | .0009 | .072 | |||||||
| sport/control x DRD4 Ex3 | F2,296=4.18 (p=.016) | .027 | .733 | |||||||
DISCUSSION
In the present study, we demonstrated elite status in combat sports x DRD4 genotype interactions in two domains of the five-factor model of personality: Openness and Conscientiousness. Specifically, Openness differed between DDR4 Ex3 VNTR genotypes, but only in the elite athletes (1.33±0.82 vs 4.36±2.36, for the L/L and S/L genotype, respectively, p=0.031), whereas Conscientiousness, although not statistically different between DRD4 genotypes in both elite athletes and healthy controls, was significantly higher in the elite athletes compared with controls, especially in the S/S homozygotes (6.98±2.34 vs 4.96±2.49, p=0.00003).
In 1996, two independent papers showed an association between dopaminergically modulated personality trait novelty seeking and the DRD4 gene [18,32]. The higher scores of novelty seeking assessed by Tridimensional Personality Questionnaire were found in carriers of the 7-repeat allele and those findings were subsequently confirmed by others [33,34]. Interestingly, in the present study, we found that the elite combat athletes homozygous for the L allele (defined as the 6-11 repeats of a 48 bp segment) had significantly lower Openness scores compared with S/L heterozygotes. It is difficult to compare our findings with previous observations, as we did not assess the novelty seeking, nor did we predict it by means of correlation (multiple regression models) between novelty seeking and NEO-FFI [35]. However, given the link between novelty seeking and openness to experience (and extraversion) [36]) our results may seem contradictory to previous findings that suggest an association between novelty seeking and the long allele of the DRD4 VNTR [11,32,33]. On the other hand, the correlation between novelty seeking and NEO-EFI openness domain may not be straightforward. According to Gocłowska et al. [36], ”both openness and extraversion are linked to novelty in a unique way, with each of the other traits explaining a somewhat different portion of variance in novelty seeking behavior”. Also, many recent studies have not found any associations between the DRD4 exon 3 polymorphism and novelty seeking or extraversion [37.38]. A recent meta-analysis of studies of the association between the DRD4 VNTR and DRD4 promoter polymorphism (-521 C/T) and several approach-related traits including novelty seeking, extraversion and impulsivity revealed that only a promoter variant may be associated with novelty seeking and impulsivity [39]. Moreover, in a genomewide association study of the FFM of personality traits in young Korean women, none of the NEO-FFI major factors were associated with the DRD4 gene [40]. Benjamin et al. [32] reported that the presence of the 7-repeat allele was also associated with lower NEO Conscientiousness scores. However, subsequent studies failed to confirm this initial finding [25,34]. Moreover, Paterson et al. [41] pointed out some methodological flaws in the original association studies. In the present study we did not find any DRD4 VNTR genotype dependent diferences in NEO Conscientiousness scores in the elite athletes or control individuals. However, this personality domain was significantly higher in the athletes compared with control individuals, yet the difference was evident only in carriers of the S/S genotype. It is not clear whether this is only a statistical phenomenon or a reflection of true biological interaction. The relationship between personality and exercise capacity has long been of interest to sport psychologists [42]. Elite athletes competing at the national and international level were found to have lower levels of neuroticism than non-elite athletes, whereas the level of conscientiousness and agreeableness was higher [43]. In another study, athletes scored higher than non-athletes for conscientiousness, but other personality traits did not differ significantly between the groups [42]. Thus, although our study is similar to previous studies with respect to the association between Conscientiousness and elite status, it is not clear whether the S allele, linked to higher scores of Conscientiousness [32], plays any role in the observed interaction pattern.
Studies investigating the DRD4 variants with respect to personality dimensions in a specialized cohort of athletes are scant [44,45,46]. In 2013, Thomson et al. [46] reported a significant association between the -521 C/T (rs1800955) polymorphism in the promoter region of the DRD4 and sport-specific sensation seeking in a high-risk sport population (skiers and snowboarders). Interestingly, another study by the same authors, in which five polymorphisms were investigated (21106T/C, 2906T/C, 2809G/A, 2291C/T, 120-bp duplication) in the promoter region of the DRD4 in a cohort of skiers and snowboarders, failed to reproduce the previous finding of association between the DRD4 and sensation seeking [47]. In a recent study, Abrahams et al. [48] investigated associations of DRD2 and DRD4 genotypes with concussion susceptibility and personality in rugby players . The authors found the association between the -521 C/T DRD4 variant and concussion susceptibility as well as socially detached behaviour.
CONCLUSIONS
Engaging in high-risk sport (e.g. snowboarding, parachuting, martial arts) may be associated with several personality characteristics. In the present study, we found an interaction between the dopamine D4 receptor gene VNTR polymorphism and athletic status in two major NEO-FFI factors: Openness and Conscientiousness. The DRD4 exon 3 polymorphism may be associated with the NEO Openness and Conscientiousness domains in martial arts athletes, thereby modulating athletes’ predisposition to participate in high risk sport. As a majority of personality traits have been linked to genetic factors, behavioral genetic studies and personality genetics represent a new promising area of research aimed at obtaining a better understanding of athletic motivation and behavior.
Acknowledgments
The study was supported by National Science Centre of Poland (No. UMO-2016/21/B/NZ7/01068)
REFERENCES
- 1.Blanco NJ, Love BC, Cooper JA, McGeary JE, Knopik VS, Maddox WT. A frontal dopamine system for reflective exploratory behavior. Neurobiol Learn Mem. 2015;22:1074–77. doi: 10.1016/j.nlm.2015.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ismael F, Baltieri DA. Role of personality traits in cocaine craving throughout an outpatient psychosocial treatment program. Rev Bras Psiquiatr. 2014;36:24–31. doi: 10.1590/1516-4446-2013-1206. [DOI] [PubMed] [Google Scholar]
- 3.Hornowska E. Badanie z wykorzystaniem kwestionariusza TCI R.C. Cloningera. Poznań: Bogucki Wydawnictwo Naukowe; 2003. Temperamentalne uwarunkowania zachowania. [in Polish]. [Google Scholar]
- 4.Hu Y, Liu X, Qiao D. Increased extracellular dopamine and 5-hydroxytryptamine levels contribute to enhanced subthalamic nucleus neural activity during exhausting exercise. Biol Sport. 2015;32:187–92. doi: 10.5604/20831862.1150299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gelernter J, Kranzler H, Satel SL. No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans. Biol Psychiatry. 1999;45:340–5. doi: 10.1016/s0006-3223(97)00537-4. [DOI] [PubMed] [Google Scholar]
- 6.Hamidovic A, Dlugos A, Skol A, Palmer AA, de Wit H. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: An exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol. 2010;17:374–83. doi: 10.1037/a0017840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lee SH, Han JH, Jin YY, Lee IH, Hong HR, Kang HS. Poor physical fitness is independently associated with mild cognitive impairment in elderly Koreans. Biol Sport. 2016;3:57–62. doi: 10.5604/20831862.1185889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Petito A, Altamura M, Iuso S, Padalino FA, Sessa F, D’Andrea G, Margaglione M, Bellomo A. The Relationship between Personality Traits, the5HTTP olymorphisms, and the Occurrence of Anxiety and Depressive Symptomsin Elite Athletes. PLoS One. 2016;11(6):e0156601. doi: 10.1371/journal.pone.0156601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Nowak J, Zawilska J. Receptory i mechanizmy przekazywania sygnału. Warszawa: PWN; 2004. [Google Scholar]
- 10.Costa PT, McCrae RR. The NEO-PI/NEOFFI Manual Supplement. Odesse, FL: Psychological Assessment Resources; 1989. [Google Scholar]
- 11.Costa PT, McCrae RR. The NEO-PI-R, Professional Manual. Odesse, FL: Psychological Assessment Resources; 1992. [Google Scholar]
- 12.Sutin AR, Terracciano A, Deiana B, Uda M, Schlessinger D, Lakatta EG, Costa PT., Jr Cholesterol, triglycerides, and the Five-Factor Model ofpersonality. Biol Psychol. 2010;84:186–91. doi: 10.1016/j.biopsycho.2010.01.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Terracciano A, Esko T, Sutin AR, de Moor MH, Meirelles O, Zhu G, Tanaka T, Giegling I, Nutile T, Realo A. Meta-analysis of genome-wide association studies identifies common variants in CTNNA2 associated with excitement-seeking. Transl Psychiatry. 2011;1:49. doi: 10.1038/tp.2011.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.De Young CG, Hirsh JB, Shane MS, Papademetris X, Rajeevan N, Gray JR. Testing predictions from personality neuroscience. Brain structure and the big five. Psychol Sci. 2010;21:820–8. doi: 10.1177/0956797610370159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Okuyama Y, Ishiguro H, Nankai M, Shibuya H, Watanabe A, Arinami T. Identification of a polymorphism in the promoter region of DRD4 associated with the human novelty seeking personality trait. Mol Psychiatry. 2000;5:64–9. doi: 10.1038/sj.mp.4000563. [DOI] [PubMed] [Google Scholar]
- 16.Löber S, Hübner H, Tschammer N, Gmeiner P. Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates. Trends Pharmacol Sci. 2011;32:148–57. doi: 10.1016/j.tips.2010.12.003. [DOI] [PubMed] [Google Scholar]
- 17.Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975–90. doi: 10.1001/archpsyc.1993.01820240059008. [DOI] [PubMed] [Google Scholar]
- 18.Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty-seeking. Nat Genet. 1996;12:78–80. doi: 10.1038/ng0196-78. [DOI] [PubMed] [Google Scholar]
- 19.Koob GF. Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci. 2000;909:170–85. doi: 10.1111/j.1749-6632.2000.tb06682.x. [DOI] [PubMed] [Google Scholar]
- 20.Mahoney JJ, ThompsonLake DGY, Cooper K, Verrico CD, Newton TF, DeLaGarza R. Acomparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. J Psychopharmacol. 2015;29:50–6. doi: 10.1177/0269881114560182. [DOI] [PubMed] [Google Scholar]
- 21.Jang KL, McCrae RR, Angleitner A, Riemann R, Livesley WJ. Heritability of facet-level traits in cross-cultural twin sample: Support for a hierarchical model of personality. J Pers Soc Psychol. 1998;74:1556–65. doi: 10.1037//0022-3514.74.6.1556. [DOI] [PubMed] [Google Scholar]
- 22.Jang KL, Livesley WJ, Vernon PA. Heritability of the big five personality dimensions and their facets: A twin study. J Pers. 1996;64:577–91. doi: 10.1111/j.1467-6494.1996.tb00522.x. [DOI] [PubMed] [Google Scholar]
- 23.Dragan W, Oniszczenko W. An association between dopamine D4 receptor and transporter gene polymorphisms and personality traits, assessed using NEO-FFI in Polish female population. Pers Individ Differ. 2007;43:531–40. [Google Scholar]
- 24.Grzywacz A, Kucharska-Mazur J, Samochowiec J. Association studies of dopamine D4 receptor gene exon 3 in patients with alcohol dependence. Psychiatr Pol. 2008;42:453–61. [PubMed] [Google Scholar]
- 25.Persson ML, Wasserman D, Geijer T, Frisch A, Rockah R, Michaelovsky E, Apter A, Weizman A, Jonsson EG, Bergman H. Dopamine D4 receptor and personality traits in healthy volunteers. Eur Arch Psychiatry Clin Neurosci. 2000;250:203–6. doi: 10.1007/s004060070025. [DOI] [PubMed] [Google Scholar]
- 26.Schoots O, Van Tol HH. The human dopamine D4 receptor repeat sequences modulate expression. Pharmacogenomics J. 2003;3:343–8. doi: 10.1038/sj.tpj.6500208. [DOI] [PubMed] [Google Scholar]
- 27.Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic cAMP levels by different human dopamine D4 receptor variants. J Neurochem. 1995;65:1157–65. doi: 10.1046/j.1471-4159.1995.65031157.x. [DOI] [PubMed] [Google Scholar]
- 28.Mitchell RJ, Howlett S, Earl L, White NG, McComb J, Schanfield MS, Briceno I, Papiha SS, Osipova L, Livshits G, Leonard WR, Crawford MH. Distribution of the 30 VNTR polymorphism in the human dopamine transporter gene in world populations. Hum Biol. 2000;72:295–304. [PubMed] [Google Scholar]
- 29.Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J. 2001;1:152–6. doi: 10.1038/sj.tpj.6500026. [DOI] [PubMed] [Google Scholar]
- 30.Greenwood TA, Kelsoe JR. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics. 2003;82:511–20. doi: 10.1016/s0888-7543(03)00142-3. [DOI] [PubMed] [Google Scholar]
- 31.Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies. Am J Epidemiol. 2009;169(4):505–14. doi: 10.1093/aje/kwn359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat. Genet. 1996;12:81–84. doi: 10.1038/ng0196-81. [DOI] [PubMed] [Google Scholar]
- 33.Noble EP, Ozkaragoz TZ, Ritchie TL, Zhang X, Belin TR, Sparkes RS. D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet. 1998;81:257–267. [PubMed] [Google Scholar]
- 34.Strobel A, Spinath F, Angleitner A, Riemann R, Lesch K-P. Lack of Association between Polymorphisms of the Dopamine D4 Receptor Gene and Personality. Neuropsychobiology. 2003;47:52–56. doi: 10.1159/000068876. [DOI] [PubMed] [Google Scholar]
- 35.Strobel A, Wehr A, Michel A, Brocke B. Association between the dopamine D4 receptor (DRD4) exon III polymorphism and measures of Novelty Seeking in a German population. Mol Psychiatry. 1999;4:378–384. doi: 10.1038/sj.mp.4000535. [DOI] [PubMed] [Google Scholar]
- 36.Gocłowska MA, Ritter SM, Elliot AJ, Baas M. Novelty seeking is linked to openness and extraversion, and can lead to greater creative performance. J Pers. 2019;87:252–266. doi: 10.1111/jopy.12387. [DOI] [PubMed] [Google Scholar]
- 37.Kuhn KU, Meyer K, Nöthen MM, Gansicke M, Papassotiropoulos A, Maier W. Allelic variants of dopamine receptor D4 (DRD4) and serotonin receptor 5-HT2C (HTR2C) and temperament factors: Replication tests. Am J Med Genet. 1999;88:168–172. [PubMed] [Google Scholar]
- 38.Pogue-Geille M, Ferrell R, Deka R, Debski T, Manuck S. Human novelty seeking personality traits and dopamine D4 receptor polymorphisms: A twin and genetic association study. Am J Med Genet. 1998;81:44–48. [PubMed] [Google Scholar]
- 39.Munafò MR, Yalcin B, Willis-Owen SA, Flint J. Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data. Biol Psychiatry. 2008;63(2):197–206. doi: 10.1016/j.biopsych.2007.04.006. [DOI] [PubMed] [Google Scholar]
- 40.Han-Na K, Seung-Ju R, Yeon Ah S, Hye Won C, Jong-Young L, Juhee C, Hocheol S, Hyung-Lae K. Genome-wide association study of the five-factor model of personality in young Korean women. J Hum Genet. 2013;58:667–674. doi: 10.1038/jhg.2013.75. [DOI] [PubMed] [Google Scholar]
- 41.Paterson AD, Sunohara GA, Kennedy JL. Dopamine D4 Receptor Gene: Novelty or Nonsense? Neuropsychopharmacology. 1999;21:3–16. doi: 10.1016/S0893-133X(98)00115-8. [DOI] [PubMed] [Google Scholar]
- 42.Malinauskas R, Dumciene A, Mamkus G, Venckunas T. Personality traits and exercise capacity in male athletes and non-athletes. Percept Mot Skills. 2014;118(1):145–161. doi: 10.2466/29.25.PMS.118k13w1. [DOI] [PubMed] [Google Scholar]
- 43.Allen MS, Greenlees I, Jones MV. An investigation of the five-factor model of personality and coping behavior in sport. J Sports Sci. 2011;29(8):841–850. doi: 10.1080/02640414.2011.565064. [DOI] [PubMed] [Google Scholar]
- 44.Filonzi L, Franchini N, Vaghi M, Chiesa S, Marzano FN. The potential role of myostatin and neurotransmission genes in elite sport performances. J Biosci. 2015;40(3):531–537. doi: 10.1007/s12038-015-9542-4. [DOI] [PubMed] [Google Scholar]
- 45.Bonisławska I, Patyna A, Wilczyński J, Urbański R, Żychowska M. Assessment of fatigue and the overtraining syndrome in female spinning instructors based on a survey and on the expression of selected genes. Balt J Health Phys Activ. 2018;10(1):46–52. [Google Scholar]
- 46.Thomson CJ, Hanna CW, Carlson SR, Rupert JL. The -521 C/T variant in the dopamine-4-receptor gene (DRD4) is associated with skiing and snowboarding behavior. Scand J Med Sci Sports. 2013;23(2):108–113. doi: 10.1111/sms.12031. [DOI] [PubMed] [Google Scholar]
- 47.Thomson CJ, Rajala AK, Carlson SR, Rupert JL. Variants in the Dopamine-4-Receptor Gene Promoter Are Not Associated with Sensation Seeking in Skiers. PLoS ONE. 2014;9(4):e93521. doi: 10.1371/journal.pone.0093521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Abrahams S, McFie S, Lacerda M, Patricios J, Suter J, September AV, Posthumus M. Unravelling the interaction between the DRD2 and DRD4 genes, personality traits and concussion risk. BMJ Open Sport Exerc Med. 2019;5(1):e000465. doi: 10.1136/bmjsem-2018-000465. [DOI] [PMC free article] [PubMed] [Google Scholar]


